ANI PHARMACEUTICALS INC 8-K

What Happened
ANI Pharmaceuticals, Inc. (ANIP) announced its quarterly earnings by issuing a press release dated May 8, 2026 reporting financial results for the quarter ended March 31, 2026. The company furnished that press release on a Form 8-K under Item 2.02 (Results of Operations and Financial Condition). The filing also includes the Inline XBRL cover page (Item 9.01).

Key Details

• Form 8-K filed May 8, 2026 (Item 2.02) furnished a press release reporting Q1 results for the period ended March 31, 2026 (Exhibit 99.1).
• Exhibit list includes Exhibit 99.1 (press release dated May 8, 2026) and the Inline XBRL Cover Page (104).
• The 8-K furnishes the press release; it does not include full quarterly financial statements or management discussion that appear in a 10-Q.

Why It Matters
This 8-K is the company’s official public disclosure of its Q1 2026 earnings announcement (earnings, revenue, quarterly results). Retail investors should read the furnished press release for the reported revenue, net income, EPS and any commentary management provided, and then review the forthcoming Form 10‑Q for complete financial statements and reconciliations. Quarterly results can affect investor sentiment and the stock price, so confirm the specific figures and compare them to prior quarters and analyst expectations.